Latest Period
Q1 2026
Security Snapshot
Elanco Animal Health Inc - Common Stock (ELAN) Institutional Ownership
CUSIP: 28414H103
13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026
Institutions Reporting
503
Shares (Excl. Options)
541,027,287
Price
$23.93
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- ELAN on NYSE
- Shares outstanding
- 496,000,719
- Price per share
- $22.15
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 541,027,287
- Total reported value
- $12,941,721,228
- % of total 13F portfolios
- 0.01%
- Share change
- +5,796,755
- Value change
- +$144,549,808
- Number of holders
- 503
- Price from insider filings
- $22.15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ELAN - Elanco Animal Health Inc - Common Stock is tracked under CUSIP 28414H103.
- 503 institutions reported positions in Q1 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 480 to 503 between Q4 2025 and Q1 2026.
- Reported value moved from $12,199,368,590 to $12,941,721,228.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 503 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 28414H103?
CUSIP 28414H103 identifies ELAN - Elanco Animal Health Inc - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 28414H103:
Significant Owners of Elanco Animal Health Inc - Common Stock (ELAN) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| DODGE & COX | 14% | -12% | $1,573,304,362 | -$231,399,478 | 68,944,100 | -13% | Dodge & Cox | 31 Mar 2026 |
| FMR LLC | 10% | -20% | $1,181,202,753 | -$287,108,530 | 52,196,321 | -20% | FMR LLC | 31 Dec 2025 |
| PRIMECAP MANAGEMENT CO/CA/ | 9.2% | $1,046,090,616 | 45,840,956 | PRIMECAP MANAGEMENT CO/CA/ | 31 Mar 2026 | |||
| BlackRock, Inc. | 8.9% | +112% | $886,598,367 | +$443,042,097 | 44,021,766 | +100% | BlackRock, Inc. | 30 Sep 2025 |
| T. Rowe Price Investment Management, Inc. | 6.4% | $635,376,116 | 31,547,970 | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $625,506,031 | 26,138,990 | Vanguard Capital Management | 31 Mar 2026 | |||
| DIMENSIONAL FUND ADVISORS LP | 4.9% | -2% | $586,934,341 | -$13,290,961 | 24,527,135 | -2.2% | Dimensional Fund Advisors LP | 31 Mar 2026 |
As of 31 Mar 2026, 503 institutional investors reported holding 541,027,287 shares of Elanco Animal Health Inc - Common Stock (ELAN). This represents 109% of the company’s total 496,000,719 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Elanco Animal Health Inc - Common Stock (ELAN) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Dodge & Cox | 14% | 68,944,100 | -13% | 0.91% | $1,649,832,313 |
| FMR LLC | 10% | 50,925,366 | -2.4% | 0.06% | $1,218,644,022 |
| BlackRock, Inc. | 9.6% | 47,622,630 | +2.8% | 0.02% | $1,139,609,540 |
| PRIMECAP MANAGEMENT CO/CA/ | 9.2% | 45,840,956 | -0.81% | 0.86% | $1,096,974,077 |
| T. Rowe Price Investment Management, Inc. | 7% | 34,635,086 | -1.7% | 0.57% | $828,818,000 |
| DIMENSIONAL FUND ADVISORS LP | 4.9% | 24,527,135 | -2.2% | 0.12% | $586,923,829 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.6% | 22,637,357 | 0% | 0.03% | $541,711,953 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 22,336,124 | 0% | 0.01% | $534,503,447 |
| STATE STREET CORP | 3.1% | 15,336,479 | +1.9% | 0.01% | $367,001,942 |
| Winslow Capital Management, LLC | 2.7% | 13,614,355 | 1.3% | $325,791,515 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 11,192,404 | +19% | 0.02% | $267,889,080 |
| Black Creek Investment Management Inc. | 2.1% | 10,493,849 | -5.1% | 13% | $251,117,807 |
| UBS Group AG | 1.7% | 8,572,057 | -1.2% | 0.04% | $205,129,324 |
| Invesco Ltd. | 1.6% | 8,141,172 | +70% | 0.03% | $194,818,245 |
| MORGAN STANLEY | 1.3% | 6,417,527 | -23% | 0.01% | $153,571,460 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1.3% | 6,229,045 | -14% | 0.13% | $149,061,047 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.2% | 6,015,064 | +4.2% | 0.48% | $143,940,481 |
| SEI INVESTMENTS CO | 1.1% | 5,650,393 | +738% | 0.12% | $135,213,937 |
| Clearbridge Investments, LLC | 0.92% | 4,581,016 | -19% | 0.1% | $109,623,704 |
| CITADEL ADVISORS LLC | 0.88% | 4,387,127 | +19% | 0.07% | $104,983,949 |
| NORTHERN TRUST CORP | 0.84% | 4,189,189 | +2% | 0.01% | $100,247,292 |
| Bank of New York Mellon Corp | 0.77% | 3,809,888 | -2.7% | 0.02% | $91,170,622 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 0.72% | 3,582,401 | -17% | 0.28% | $85,726,856 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.72% | 3,577,850 | +1% | 0.01% | $85,617,951 |
| Capital World Investors | 0.69% | 3,408,331 | +64% | 0.01% | $81,561,361 |
Institutional Holders of Elanco Animal Health Inc - Common Stock (ELAN) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 541,027,287 | $12,941,721,228 | +$144,549,808 | $23.93 | 503 |
| 2025 Q4 | 539,050,925 | $12,199,368,590 | -$765,097,720 | $22.63 | 480 |
| 2025 Q3 | 570,844,069 | $11,496,298,982 | +$680,262,488 | $20.14 | 406 |
| 2025 Q2 | 538,352,937 | $7,687,668,693 | +$655,647,979 | $14.28 | 362 |
| 2025 Q1 | 494,022,445 | $5,187,492,485 | +$2,004,620 | $10.50 | 359 |
| 2024 Q4 | 489,345,019 | $5,925,862,528 | +$26,438,350 | $12.11 | 387 |
| 2024 Q3 | 481,862,274 | $7,076,192,785 | -$28,345,131 | $14.69 | 384 |
| 2024 Q2 | 482,171,600 | $6,957,441,182 | +$6,686,922 | $14.43 | 396 |
| 2024 Q1 | 480,177,163 | $7,816,997,297 | +$26,389,803 | $16.28 | 370 |
| 2023 Q4 | 479,962,841 | $7,151,250,374 | +$21,579,978 | $14.90 | 349 |
| 2023 Q3 | 481,442,000 | $5,409,895,330 | +$102,163,765 | $11.24 | 344 |
| 2023 Q2 | 473,375,354 | $4,760,610,377 | -$67,531,728 | $10.06 | 345 |
| 2023 Q1 | 479,522,703 | $4,495,944,050 | -$110,942,259 | $9.40 | 384 |
| 2022 Q4 | 481,681,648 | $5,908,155,843 | +$232,156,887 | $12.22 | 398 |
| 2022 Q3 | 463,043,345 | $5,755,609,685 | -$196,296,127 | $12.41 | 398 |
| 2022 Q2 | 470,431,046 | $9,236,728,928 | -$88,523,747 | $19.63 | 421 |
| 2022 Q1 | 473,375,688 | $12,362,622,405 | -$47,241,309 | $26.09 | 454 |
| 2021 Q4 | 475,123,500 | $13,465,426,403 | +$218,382,206 | $28.38 | 461 |
| 2021 Q3 | 467,401,656 | $14,907,014,269 | -$71,757,204 | $31.89 | 435 |
| 2021 Q2 | 468,283,929 | $16,250,367,215 | +$128,764,524 | $34.69 | 464 |
| 2021 Q1 | 467,015,636 | $13,752,652,796 | +$242,000,095 | $29.45 | 433 |
| 2020 Q4 | 458,146,787 | $14,050,001,284 | +$1,375,218,703 | $30.67 | 424 |
| 2020 Q3 | 413,516,389 | $11,539,620,540 | +$535,290,448 | $27.93 | 348 |
| 2020 Q2 | 396,250,140 | $8,506,918,630 | -$172,335,832 | $21.45 | 355 |
| 2020 Q1 | 402,762,228 | $9,017,316,731 | +$571,966,377 | $22.39 | 350 |
| 2019 Q4 | 369,452,160 | $10,879,469,608 | -$57,025,660 | $29.45 | 390 |
| 2019 Q3 | 371,517,866 | $9,877,782,405 | -$152,630,501 | $26.59 | 359 |
| 2019 Q2 | 374,935,481 | $12,675,665,904 | +$446,834,964 | $33.80 | 364 |
| 2019 Q1 | 373,768,060 | $11,987,183,816 | +$9,247,514,461 | $32.07 | 342 |
| 2018 Q4 | 85,024,329 | $2,681,019,350 | +$393,741,056 | $31.53 | 164 |
| 2018 Q3 | 71,099,284 | $2,480,509,428 | +$2,480,239,432 | $34.89 | 153 |
| 2016 Q2 | 0 | $0 | -$6,000 | $22.15 | 0 |
| 2016 Q1 | 186 | $6,000 | $32.26 | 1 |